Fuji Pharma Acquires DKSH's OICL

News: Japanese drugmaker Fuji Pharma signed an agreement with Swiss trading company DKSH on August 6 2012 to purchase the OLIC contract manufacturing facility in Thailand. The facility is part of DKSH's business unit healthcare. The purchase of OLIC will enable Fuji Pharma to expand its presence outside Japan, Fuji Pharma's CEO and President Hirofumi Imai said. The acquisition worth US$53mn will add a bestin-class contract manufacturing business to Fuji Pharma's portfolio, Imai added.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare
Geography: Japan, Thailand, Japan, Thailand, Thailand

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.